ĀÜĄņĀŅĀ×

Sujin JUNG has extensive experience in the pharmaceutical industry, with a focus on clinical development, regulatory operations, and medical affairs. Sujin has held various leadership roles at companies like Bridge Biotherapeutics, Odonate Therapeuticsā„¢, and Eli Lilly and Company, where Sujin has managed clinical trials, regulatory submissions, and site activation processes. Sujin has also worked as a training instructor at Pusan National University and as a pharmacist at Samsung Medical Center. Sujin holds a Bachelor's degree in Pharmacy, a Master's degree in Pharmaceutical Outcomes research from Chung-Ang University, and is currently pursuing a Global Clinical Scholars Research Training degree at Harvard Medical School.